Sub-Total: $0.00
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Complimentary
Related products
-
New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Read more -
Emerging Treatment Options for Pustular Psoriasis
Read more -
Emerging Strategies in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Read more -
Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures
Read more
